Gastroenterology Research and Practice

Peritoneal Metastases


Publishing date
20 Jul 2012
Status
Published
Submission deadline
02 Mar 2012

Lead Editor

1Peritoneal Carcinomatosis Center, NPO Organization to support Peritoneal Surface Malignancy Treatment, Japan; Kishiwada Tokushukai Hospital, Osaka, Japan; Kusatsu General Hospital, Shiga, Japan; Ikeda Hospital, Shizuoka, Japan

2Department of Oncology, Zhongnan Hospital of Wuhan University, No 169, Donghu Road, Wuchang District, Wuhan 430071, China

3Program in Peritoneal Surface Malignancy, Washington Hospital Center, 106 Irving Street, NW, P.O. Box 3900, Washington, DC 20010, USA

4St. John of God Hospital and University of Regensburg, Ratisbon, Germany


Peritoneal Metastases

Description

The current state-of-the-art treatment for peritoneal carcinomatosis consists of a comprehensive management strategy using cytoreductive surgery and perioperative intraperitoneal/systemic chemotherapy. A paradigm shift occurred after the introduction of the treatment, and now the peritoneal carcinomatosis is the disease which can be cured.

In this special issue, we particularly take an interest in manuscripts that deal with any aspects of peritoneal metastases. Potential topics include, but are not limited to:

  • The mechanisms of the formation of peritoneal carcinomatosis
  • Diagnosis of PC
  • Pharmacokinetics of perioperative chemotherapy
  • Surgical techniques of peritonectomy
  • Perioperative chemotherapy
  • Morbidity, mortality, and postoperative care
  • Indication of the strategy
  • Long-term results and treatment failure

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/grp/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2012
  • - Article ID 695351
  • - Editorial

Peritoneal Metastases

Yutaka Yonemura | Yan Li | ... | Pompiliu Piso
  • Special Issue
  • - Volume 2012
  • - Article ID 741202
  • - Clinical Study

Laparoscopic Diagnosis and Laparoscopic Hyperthermic Intraoperative Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Detected by CT Examination

Masamitsu Hirano | Yutaka Yonemura | ... | Akiyoshi Mizumoto
  • Special Issue
  • - Volume 2012
  • - Article ID 635314
  • - Research Article

Pulmonary Complications following Cytoreductive Surgery and Perioperative Chemotherapy in 147 Consecutive Patients

Vinicius Preti | David Chang | Paul H. Sugarbaker
  • Special Issue
  • - Volume 2012
  • - Article ID 890450
  • - Clinical Study

Adjuvant Bidirectional Chemotherapy with Intraperitoneal Pemetrexed Combined with Intravenous Cisplatin for Diffuse Malignant Peritoneal Mesothelioma

Lana Bijelic | O. Anthony Stuart | Paul Sugarbaker
  • Special Issue
  • - Volume 2012
  • - Article ID 163284
  • - Research Article

Systemic Chemotherapy prior to Cytoreductive Surgery and HIPEC for Carcinomatosis from Appendix Cancer: Impact on Perioperative Outcomes and Short-Term Survival

Lana Bijelic | Anjali S. Kumar | ... | Paul H. Sugarbaker
  • Special Issue
  • - Volume 2012
  • - Article ID 752643
  • - Research Article

Adjuvant Bidirectional Chemotherapy Using an Intraperitoneal Port

Paul H. Sugarbaker | Lana Bijelic
  • Special Issue
  • - Volume 2012
  • - Article ID 541842
  • - Review Article

Diagnosis and Management of Peritoneal Metastases from Ovarian Cancer

Evgenia Halkia | John Spiliotis | Paul Sugarbaker
  • Special Issue
  • - Volume 2012
  • - Article ID 309417
  • - Research Article

Cytoreductive Surgery Plus Hyperthermic Perioperative Chemotherapy for Selected Patients with Peritoneal Metastases from Colorectal Cancer: A New Standard of Care or an Experimental Approach?

Paul H. Sugarbaker
  • Special Issue
  • - Volume 2012
  • - Article ID 690256
  • - Review Article

Pulmonary Metastasis from Pseudomyxoma Peritonei

Toshiyuki Kitai
  • Special Issue
  • - Volume 2012
  • - Article ID 827534
  • - Research Article

Hyperthermic Intraperitoneal Chemotherapy with Melphalan: A Summary of Clinical and Pharmacological Data in 34 Patients

Lana Bijelic | Paul H. Sugarbaker | O. Anthony Stuart
Gastroenterology Research and Practice
 Journal metrics
Acceptance rate25%
Submission to final decision63 days
Acceptance to publication29 days
CiteScore3.400
Impact Factor1.806
 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.